These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23495241)

  • 1. Circulating microRNA as a biomarker of human growth hormone administration to patients.
    Kelly BN; Haverstick DM; Lee JK; Thorner MO; Vance ML; Xin W; Bruns DE
    Drug Test Anal; 2014 Mar; 6(3):234-8. PubMed ID: 23495241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use and Abuse of Human Growth Hormone in Sports.
    Siebert DM; Rao AL
    Sports Health; 2018; 10(5):419-426. PubMed ID: 29932857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects.
    Okano M; Nishitani Y; Sato M; Ikekita A; Kageyama S
    Drug Test Anal; 2010; 2(11-12):548-56. PubMed ID: 21249726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
    Di Luigi L; Rigamonti AE; Agosti F; Mencarelli M; Sgrò P; Marazzi N; Cella SG; Müller EE; Sartorio A
    Eur J Endocrinol; 2009 May; 160(5):753-8. PubMed ID: 19258430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker detection of rhGH doping: an excretion study.
    Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
    Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of doping with rhGH: excretion study with WADA-approved kits.
    Jing J; Yang S; Zhou X; He C; Zhang L; Xu Y; Xie M; Yan Y; Su H; Wu M
    Drug Test Anal; 2011; 3(11-12):784-90. PubMed ID: 22147343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
    Leuenberger N; Saugy M
    Adv Exp Med Biol; 2015; 888():401-8. PubMed ID: 26663194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports.
    Bidlingmaier M; Suhr J; Ernst A; Wu Z; Keller A; Strasburger CJ; Bergmann A
    Clin Chem; 2009 Mar; 55(3):445-53. PubMed ID: 19168559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and protein biomarkers in blood for the improved detection of GH abuse.
    Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
    J Pharm Biomed Anal; 2016 Sep; 128():111-118. PubMed ID: 27243825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of fibronectin 1 in one dried blood spot and in urine after rhGH treatment.
    Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
    Drug Test Anal; 2017 Jul; 9(7):1011-1016. PubMed ID: 27717280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating nucleic acids in the assessment of endogenous growth hormone production.
    Thakkar H; Butt AN; Powrie J; Holt R; Swaminathan R
    Ann N Y Acad Sci; 2008 Aug; 1137():58-65. PubMed ID: 18837926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport.
    Cox HD; Rampton J; Eichner D
    Anal Bioanal Chem; 2013 Feb; 405(6):1949-58. PubMed ID: 23263515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors.
    Okano M; Nishitani Y; Sato M; Kageyama S
    Drug Test Anal; 2012 Sep; 4(9):692-700. PubMed ID: 22733714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNAs: a new generation of anti-doping biomarkers.
    Leuenberger N; Robinson N; Saugy M
    Anal Bioanal Chem; 2013 Dec; 405(30):9617-23. PubMed ID: 24077830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects.
    Ding J; Okada S; Jørgensen JO; Kopchick JJ
    Proteomics; 2011 Sep; 11(17):3565-71. PubMed ID: 21751372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone in sport: beyond Beijing 2008.
    Segura J; Gutiérrez-Gallego R; Ventura R; Pascual JA; Bosch J; Such-Sanmartín G; Nikolovski Z; Pinyot A; Pichini S
    Ther Drug Monit; 2009 Feb; 31(1):3-13. PubMed ID: 19155963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone doping in sports: a critical review of use and detection strategies.
    Baumann GP
    Endocr Rev; 2012 Apr; 33(2):155-86. PubMed ID: 22368183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
    Rogol AD
    Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
    Nelson AE; Ho KK
    Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.